Humana Inc. (NYSE:HUM) Short Interest Update

Humana Inc. (NYSE:HUM) was the recipient of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 4,580,000 shares, a drop of 11.6% from the January 15th total of 5,180,000 shares. Approximately 3.8% of the company’s shares are short sold. Based on an average daily trading volume, of 1,790,000 shares, the short-interest ratio is presently 2.6 days.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.32% of the stock is currently owned by insiders.

Institutional Trading of Humana

Institutional investors have recently added to or reduced their stakes in the business. AMF Tjanstepension AB boosted its holdings in shares of Humana by 166.8% in the 3rd quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock valued at $12,686,000 after buying an additional 25,041 shares during the period. Exchange Traded Concepts LLC bought a new position in Humana in the third quarter worth about $348,000. Bleakley Financial Group LLC boosted its stake in Humana by 14.8% in the third quarter. Bleakley Financial Group LLC now owns 1,841 shares of the insurance provider’s stock valued at $583,000 after acquiring an additional 237 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Humana by 1.3% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,963 shares of the insurance provider’s stock valued at $4,423,000 after purchasing an additional 179 shares during the last quarter. Finally, Stonegate Investment Group LLC raised its position in shares of Humana by 51.4% during the 3rd quarter. Stonegate Investment Group LLC now owns 893 shares of the insurance provider’s stock worth $283,000 after purchasing an additional 303 shares during the period. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Piper Sandler increased their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Barclays raised their target price on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Cantor Fitzgerald reissued a “neutral” rating and set a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Finally, Truist Financial increased their price objective on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Nineteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $285.68.

Humana Stock Up 1.3 %

NYSE:HUM traded up $3.41 during mid-day trading on Tuesday, reaching $257.24. The stock had a trading volume of 1,418,958 shares, compared to its average volume of 1,706,863. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The company has a market capitalization of $30.97 billion, a price-to-earnings ratio of 22.78, a price-to-earnings-growth ratio of 2.11 and a beta of 0.56. Humana has a 1-year low of $213.31 and a 1-year high of $406.46. The stock’s 50 day simple moving average is $270.62 and its two-hundred day simple moving average is $292.21.

Humana (NYSE:HUM) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities analysts anticipate that Humana will post 16.11 EPS for the current year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.